US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 12.900
  • -0.660-4.87%
Close Dec 13 16:00 ET
  • 12.940
  • +0.040+0.31%
Post 20:01 ET
1.31BMarket Cap-2.37P/E (TTM)

Intellia Therapeutics Key Stats

Intellia Therapeutics Q3 2024 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
7.50M
9.11M
+1.61M
Beat Est.
-37.47%
-24.02%
+21.50%
EPS
-1.39
-1.34
+0.05
Beat Est.
-0.38%
+2.90%
+3.26%
Strong Buy

Dec 14, 2024

Intellia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 9.361M--
--2024/Q4-- / 8.895M--
Nov 7, 20242024/Q39.111M / 7.499M--
Aug 8, 20242024/Q26.957M / 18.249M--
May 9, 20242024/Q128.935M / 9.065M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 9.361M--
--2024/Q4-- / 8.895M--
Nov 7, 20242024/Q39.111M / 7.499M--
Aug 8, 20242024/Q26.957M / 18.249M--
May 9, 20242024/Q128.935M / 9.065M--

Unlock Free Earnings Estimates

Intellia Therapeutics Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 14, 2024

Strong Buy

  • Buy

    80.95%
  • Hold

    19.05%
  • Sell

    0.00%

Price Target

No Data